Lack of Correlation of Mean Corpuscular Volume to White Blood Cell Ratio to Thiopurine Levels.
Jan de Laffolie, Sibylle Koletzko, Stephan Buderus...
https://pubmed.ncbi.nlm.nih.gov/32079979Actively Recruiting
Age: 0 - 18Years
All Genders
ID06606756
CEDATA GPGE Patient Registry for Children and Adolescents With IBD
Led by University of Giessen · Updated on 2024-09-23
6300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting clinical data on children and adolescents with inflammatory bowel disease (IBD) from specialized pediatric gastroenterology centers in German-speaking countries. This patient registry aims to gather real-world information to help understand IBD better without altering patient treatments. The project is coordinated by a group of 15 experts who meet twice a year to guide research and improve quality. Participating centers enter patient data through a secure, validated online platform at the start and during follow-up of the disease. The collected information is pseudonymized to protect privacy and is then summarized and shared back with the centers in an aggregated form. This approach allows centers to track clinical progress without influencing therapeutic decisions. Participants are involved by having their clinical data recorded periodically throughout their disease course. The main outcome measured is clinical remission status. The registry operates as an observational study without direct interventions or treatments assigned. Data collection continues over many years to support ongoing research and quality improvement initiatives in pediatric IBD care.
CONDITIONS
Brief Title
CEDATA GPGE - a Patient Registry for Children and Adolescents With Inflammatory Bowel Disease
Who Can Participate
Age: 0 - 18Years
All Genders
Eligibility Criteria
You may qualify if you...
- Diagnosed with inflammatory bowel disease (IBD)
- Under 18 years of age
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Long-term Monitoring
Duration - Up to 10 years
Participants who undergo routine care are observed through data collected in a patient registry without intervention.
Data entries occur periodically as part of routine clinical care
Trial Site Locations
Total: 1 location
1
University Giessen
Giessen, Germany, 35392
Actively Recruiting
Loading map...
Research Team
J
Jan de Laffolie, MD
S
Studienzentrale KIA
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000-2014 -a 15-year evaluation of trends.
Ivana Kern, Olaf Schoffer, Thomas Richter...
https://pubmed.ncbi.nlm.nih.gov/36084003Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry.
Ivana Kern, Olaf Schoffer, Wieland Kiess...
https://pubmed.ncbi.nlm.nih.gov/33395450Fecal calprotectin and platelet count predict histologic disease activity in pediatric ulcerative colitis: results from a projection-predictive feature selection.
B Schiller, E Wirthgen, F Weber...
https://pubmed.ncbi.nlm.nih.gov/38709314Running Behind "POPO"-Impact of Predictors of Poor Outcome for Treatment Stratification in Pediatric Crohn's Disease.
Jan de Laffolie, Klaus-Peter Zimmer, Keywan Sohrabi...
https://pubmed.ncbi.nlm.nih.gov/34513855The Care of Children and Adolescents with Chronic Inflammatory Bowel Disease: A Cluster-Randomized Trial on Improving the Guideline Conformity of Treatment by the Use of the CEDATA-GPGE Patient Registry.
Luisa Tischler, Aletta Boerkoel, Heiko Krause...
https://pubmed.ncbi.nlm.nih.gov/39163213Prevalence of Anemia in Pediatric IBD Patients and Impact on Disease Severity: Results of the Pediatric IBD-Registry CEDATA-GPGE®.
Jan de Laffolie, Martin W Laass, Dietmar Scholz...
https://pubmed.ncbi.nlm.nih.gov/29358946[Crohn's Disease Exclusion Diet - an alternative to exlusive enteral nutritional therapy in children and adolescents with Crohn's disease? Statement of the GPGE working groups CEDATA and Nutrition/Nutrition Medicine].
Jan de Laffolie, Tobias Schwerd, Annette Simon...
https://pubmed.ncbi.nlm.nih.gov/32947634Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry.
Stephan Buderus, Dietmar Scholz, Rolf Behrens...
https://pubmed.ncbi.nlm.nih.gov/25759978Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA-GPGE Registry.
Annecarin Brückner, Katharina J Werkstetter, Jan de Laffolie...
https://pubmed.ncbi.nlm.nih.gov/28604511